Blog
The AMCP Blog is your go-to resource to hear from managed care experts and their perspectives on trends and hot topics related to managed care pharmacy.
In a historic decision in December, the FDA approved the first gene therapy utilizing CRISPR, an innovative type of genome editing technology. This significant moment means that the novel therapy Casgevy is approved for the treatment of sickle cell disease—which affects 100,000 Americans—in patients 12 years of age and older.
The MVP Act is a top federal policy priority for AMCP. This important bipartisan bill will enhance Medicaid patient access to new, high-cost therapies by modernizing the framework for value-based purchasing arrangements.
AMCP's most recent Partnership Forum drew participants from a range of backgrounds and perspectives to discuss the value of collaboration between health plans/payers and patient advocacy organizations in managed care pharmacy decision-making. Senior VP of Professional and Government Affairs Jennifer Mathieu shares key insights and takeaways from the event.
JMCP’s Editor-in-Chief shares three reasons to check out JMCP’s new website, including the Managed Care Pharmacy Primer Series, timely papers on implementation of the IRA, and JMCP’s policy on AI.
Last week, AMCP hosted its second IRA workshop, convening stakeholders to help unpack the complexities of the Inflation Reduction Act and discuss what’s on the horizon. In her latest blog, AMCP CEO Susan Cantrell reflects on the takeaways.
Nearly 3,000 managed care professionals from health plans, PBMs, pharmaceutical manufacturers, and other managed care organizations convened in Orlando from Oct. 16–19 for AMCP Nexus 2023, the industry’s premier fall meeting.
The world of prescription drug care and coverage can be complicated. Read AMCP CEO Susan Cantrell’s blog on AMCP’s inaugural “Access, Affordability, & Outcomes: The Value of Managed Care Pharmacy” annual report to learn how we’re making it more understandable
With October devoted to National Pharmacy Awareness, AMCP CEO Susan Cantrell talks about the outstanding efforts of managed care pharmacists across the United States in her latest blog.
From best practices in managing obesity to the latest and greatest in gene and cell therapies, guest blogger Steve Kheloussi highlights three reasons he will be attending AMCP eLearning Day.
In her latest blog, AMCP CEO Susan Cantrell recaps our inaugural workshop on the IRA, reinforcing that there is still a great deal of uncertainty as key milestones approach. Learn how AMCP is addressing concerns this landmark legislation is causing across managed care pharmacy and the larger healthcare industry.
In June, AMCP hosted the Deep Dive into Prescription Digital Therapeutics Summit, convening expert panelists and attendees from across the industry. Read 10 key takeaway points from the Summit.
A rapidly evolving area of interest is digital therapeutics, evidence-based software interventions used to treat, manage, or as an adjunct treatment for various medical conditions. Here are three reasons why you should attend the Virtual AMCP Summit: Deep Dive into Prescription Digital Therapeutics.
